SCHEMBL10285290

SCHEMBL10285290

CC(C)(C)OC(=O)N[C@H]1CCCC[C@H]1Nc1ccc(C#N)c(Nc2cccc(-n3nccn3)c2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SYK P43405 16/20 0.57
▸ KCNH2 Q12809 4/20 0.57
▸ JAK2 O60674 3/20 0.44
▸ ZAP70 P43403 2/20 0.44
▸ FLT3 P36888 2/20 0.44
▸ LCK P06239 1/20 0.44
▸ YES1 P07947 1/20 0.44
▸ LYN P07948 1/20 0.44
▸ FGR P09769 1/20 0.44
▸ SRC P12931 1/20 0.44
▸ PRKCA P17252 1/20 0.44
▸ MAP3K9 P80192 1/20 0.44
▸ PAK5 Q9P286 1/20 0.44
▸ FER P16591 3/20 0.41
▸ ROCK2 O75116 1/20 0.39
▸ MAP4K4 O95819 1/20 0.39
▸ HCK P08631 1/20 0.39
▸ ROS1 P08922 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ PRKACA P17612 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10250504 0.88 SYK (0.46) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL14961882 0.88 SYK (0.56) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL10250835 0.86 SYK (0.46) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL5025994 0.86 SYK (0.43) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL10251180 0.85 SYK (0.56) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL9105548 0.85 FER (0.61) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL10250862 0.84 SYK (0.44) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL10251527 0.80 SYK (0.40) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL16202665 0.79 SYK (0.48) SYKKCNH2JAK2ZAP70FLT3
SCHEMBL10250765 0.79 SYK (0.48) SYKJAK2FLT3FERROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3176154-B1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS PORTOLA PHARM INC (US) 2019-02-20 — — EP disclosed
US-9902688-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2018-02-27 — — US disclosed
EP-3176154-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS Portola Pharmaceuticals, Inc. (US) 2017-06-07 — — EP disclosed
US-20160318852-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS ALEXION PHARMACEUTICALS, INC. 2016-11-03 — — US disclosed
US-9359375-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2016-06-07 — — US disclosed
US-20150038492-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS ALEXION PHARMACEUTICALS, INC. 2015-02-05 — — US disclosed
US-8846928-B2 Benzamides and nicotinamides as Syk modulators PORTOLA PHARMACEUTICALS, INC. (US) 2014-09-30 — — US disclosed
US-20120142671-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS PORTOLA PHARMACEUTICALS, INC. (US) 2012-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120142671-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK SYK 1/4885KCNH2 1860/4885JAK2 29/4885
US-20160318852-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK SYK 1/4885KCNH2 1860/4885JAK2 29/4885
US-20150038492-A1 BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS SYK, BTK, NADK SYK 1/4885KCNH2 1860/4885JAK2 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback